IRCT20180305038953N1 IRCT 2018-05-15 Sarem Fertility and Infertility Research Center (SAFIR) Mannitol efficacy in ovarian hyper stimulation syndrome Efficacy Assessment of Mannitol vs Albumin in Management of Ovarian Hyperstimulation Syndrome – A randomized controlled trial 2017-03-21 anticipated 40 Complete https://irct.ir/trial/30722 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Block, individual randomization, using software; not blinded. 3 Ovarian hyper stimulation syndrome. Intervention 1: Intervention group: Intravenous infusion of 500 ml Mannitol 20% at the same time with 500 ml Glucose 5% using y-site over 4 hours daily or twice a day a (based on clinical responses). Intravenous solutions are the products of Shahid Ghazi (Tabriz- Iran) factories. Intervention 2: Control group: Intravenous infusion of 100g Human Albumin (5 vials of 20% Albumin) over 4 hours, repeating every 4 ti 12 hours (based on clinical responses). Albumin vials are the product of OCTAPHARMA AG- Switzerland. Yes - There is a plan to make this available What will be shared: All information on the main outcomes of the study is available for sharing. When: The beginning of the access period is 6 months after the publication of the results of the study. To whom: Official assessors of the research field of the Iran University of Medical Sciences (IUMS) Conditions: - To verify the accuracy of the analysis of the study - Modeling for future studies - Use for future meta analyzes Where to obtain: Sarem Fertility and Infertility Research Center (SAFIR) How to obtain: The official application to "Iran University of Medicalscience (IUMS)" will be communicated to the "Sarem Fertility and Infertility Research Center (SAFIR)" after being approved by the competent authorities. After receiving the request, SAFIR will contact the applicant within 10 days to answer the questions. Comments: